D

Precision BioSciences
D

DTIL

4.57000
USD
-0.14
(-2.97%)
Market Closed
Volume
0
EPS
4
Div Yield
-
P/E
12
Market Cap
35,056,740
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -3.355
    (-1.37%)
    242.150 USD
    B
    BEAM
    -0.315
    (-1.09%)
    28.705 USD
    C
    CRSP
    -0.220
    (-0.54%)
    40.500 USD
    E
    EDIT
    -0.06000
    (-4.55%)
    1.26000 USD
    N
    NTLA
    -0.090
    (-0.74%)
    12.100 USD
    REGN
    REGN
    12.38
    (1.76%)
    714.98 USD
    S
    SGMO
    -0.10000
    (-4.02%)
    2.39000 USD
    T
    TECH
    -0.450
    (-0.61%)
    72.780 USD
    V
    VYGR
    -0.03000
    (-0.52%)
    5.73000 USD
    More
News

Title: Precision BioSciences

Sector: Healthcare
Industry: Biotechnology
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.